CMH
Jhelum, Punjab, Pakistan
Military hospital
WM8X+G79, Pind dadan Khan - Jhelum Rd, Jhelum Cantt, Jhelum, Punjab
About CMH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at CMH
During the past decade, CMH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
2006-10-01
2016-12-31
Completed
4,945
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
2013-04-01
2030-01-01
Active, not recruiting
1,900
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
2014-08-18
2026-10-10
Active, not recruiting
450
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
2014-07-22
2023-12-31
Active, not recruiting
280
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
2015-04-29
2031-03-29
Active, not recruiting
415
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
2015-07-01
2023-11-01
Recruiting
782
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at CMH
According to Clinical.Site data, the most researched conditions in "CMH" are
"Hemodynamic Rebound" (1 trials) and "Placenta Previa" (1 trials). Many other conditions were trialed in "CMH" in a lesser frequency.
Clinical Trials Intervention Types at CMH
Most popular intervention types in "CMH" are "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Balloon Tamponade or B-Lynch" (1 trials) and "Tracheal Intubation" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CMH
The vast majority of trials in "CMH" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at CMH
Currently, there are NaN active trials in "CMH".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in CMH,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CMH, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".